Shilpa Medicare Ltd.
Snapshot View

246.30 -2.95 ▼-1.2%

02 February 2023, 04:01:00 PM
Volume: 4,696

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.vbshilpa.com
Market Cap 2,107.98 Cr.
Enterprise Value(EV) 2,853.00 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 2.45 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 100.37 Trailing Twelve Months Ending 2022-09
Industry PE 32.44 Trailing Twelve Months Ending 2022-09
Book Value / Share 207.01 Trailing Twelve Months Ending 2022-09
Price to Book Value 1.19 Calculated using Price: 246.30
Dividend Yield 0.45 Period Ending 2022-03
No. of Shares Subscribed 8.68 Cr. 86,801,898 Shares
FaceValue 1
Company Profile
Shilpa Medicare, established in 1987, has carved a niche for itself in the exceedingly competitive and quality-conscious sphere of pharmaceuticals manufacturing. It produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.18%
1 Week
-0.44%
1 Month
-11.88%
3 Month
-21.49%
6 Month
-40.86%
1 Year
-51.75%
2 Year
-42.61%
5 Year
-53.19%
10 Year
+168.62%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 20.98 15.40 17.66 12.85 9.93 9.59 12.23 10.41 3.67
Return on Capital Employed (%) 20.48 17.90 19.69 15.28 11.13 10.45 12.38 10.73 5.94
Return on Assets (%) 12.23 9.18 11.41 8.69 6.92 7.04 8.59 6.33 2.20

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 396 547 639 987 1,085 1,198 1,329 1,479 1,822 1,797
Non Curr. Liab. 105 154 67 251 153 167 257 561 453 339
Curr. Liab. 167 189 222 237 266 253 411 543 612 856
Minority Int. 10 14 2 -3 -5 -8 -8 -11 -11 -9
Equity & Liab. 678 905 931 1,472 1,499 1,610 1,989 2,632 2,876 2,983
Non Curr. Assets 444 577 577 742 827 1,065 1,365 1,730 1,988 2,074
Curr. Assets 234 328 354 730 672 545 624 819 887 909
Misc. Exp. not W/O 0 0
Total Assets 678 905 931 1,472 1,499 1,610 1,989 2,632 2,876 2,983

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 571 614 716 779 789 733 908 901 1,146 1,137
Other Income 9 7 11 29 33 16 22 40 21 23
Total Income 581 621 728 809 821 749 930 941 1,166 1,160
Total Expenditure -455 -487 -556 -618 -638 -579 -693 -729 -948 -985
PBIDT 125 133 171 191 184 170 237 212 218 175
Interest -4 -4 -4 -3 -3 -4 -5 -22 -41 -42
Depreciation -23 -21 -23 -31 -37 -42 -44 -54 -80 -89
Taxation -20 -35 -36 -42 -34 -26 -33 -49 -42 -16
Exceptional Items -3 0 -2 -5 20 61 9 0
PAT 75 73 105 104 103 110 155 146 61 28
Minority Interest 1 1 4 3 2 3 2 2 0 -2
Share Associate -5
Other Related Items
Consolidated Net Profit 76 74 108 108 105 112 156 148 61 21
Adjusted EPS 10 10 14 13 13 14 19 18 7 2

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 44 70 69 129 37 45 147 124 47 105
Cash Fr. Inv. -95 -49 -195 -109 -262 -9 -196 -290 -404 -286
Cash Fr. Finan. 66 -28 136 -20 313 -61 10 176 436 83
Net Change 15 -7 10 0 88 -25 -39 10 79 -98
Cash & Cash Eqvt 17 9 18 6 100 74 34 44 123 25

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 53.25 53.25 53.25 53.25 50.01 50.01 50.01 50.01 50.01
Public 46.75 46.75 46.75 46.75 49.99 49.99 49.99 49.99 49.99
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.81 0.81 0.81 0.81 0.81 0.81 0.81 0.81 1.38

Announcements View Details >>

Thu, 19 Jan 2023
Submission In Compliance With Regulation 76 Of The Securities And Exchange Board Of India (Depositories And Participants) Regulations 2018 For Quarter Ended 31 December 2022.
Pursuant to Regulation 76 of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 please find herewith enclosed the Reconciliation of Share Capital Audit Report for Equity Shares dated 18 January 2023 for the Quarter ended 31 December 2022 issued by CS D.S. Rao Practicing Company Secretary Hyderabad.
Thu, 19 Jan 2023
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on January 19 2023 for Dharmavati Bhutada & Others
Thu, 19 Jan 2023
Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on January 19 2023 for Dharmavati Bhutada & Others

Technical Scans View Details >>

Thu, 02 Feb 2023
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 3 Months High Decrease in 3 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 241,852.96 1,008.00 -0.6%
Divi's Laboratories Ltd. 86,732.57 3,271.90 -2.5%
Cipla Ltd. 82,728.22 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. 72,771.66 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. 60,864.05 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. 52,144.29 1,541.15 +0.5%
Zydus Lifesciences Ltd. 43,787.95 432.60 -0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.42 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-09 29.03 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-12 31.36 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.95 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.52 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.77 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-09 22.59 432.60 -0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.37 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-09 7.16 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-12 3.65 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.30 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.17 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.18 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-09 2.63 432.60 -0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 432.60 -0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 432.60 -0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 432.60 -0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 432.60 -0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,008.00 -0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,271.90 -2.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,024.95 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,366.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,234.95 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,541.15 +0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 432.60 -0.7%

FAQ's On Shilpa Medicare Ltd.

What is Shilpa Medicare share price?

Can I buy Shilpa Medicare shares now?

What is the Dividend Yield of Shilpa Medicare?

What is the Market Cap of Shilpa Medicare?

What are the key metrics to analyse Shilpa Medicare?

What is the 52 Week High and Low of Shilpa Medicare?

What is the trend of Shilpa Medicare share price?